Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Protein Metric Ink Proteomics Software Licensing Deal

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced a non-exclusive licensing deal for Protein Metrics' Byonic database search software.

The deal was announced in conjunction with Thermo Fisher's launch of its Thermo Scientific Proteome Discoverer software version 2.0 for qualitative and quantitative proteomics data. The Byonic software will be integrated into Proteome Discoverer. The agreement, Thermo Fisher said, adds "next-generation capability to streamline analysis of glycopeptides and other post-translational modification data."

Protein Metrics' Preview software, which samples MS/MS data to measure mass errors, digestion specificity, and modifications for full protein database search, will also be available now through Thermo Fisher.

Financial and other terms of the deal were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.